| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,205 |
9,484 |
$757K |
| 99199 |
Unlisted special service, procedure or report |
62,865 |
36,718 |
$363K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,599 |
2,825 |
$328K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,809 |
2,526 |
$274K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,772 |
1,552 |
$163K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,774 |
1,536 |
$159K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,082 |
883 |
$133K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
5,999 |
5,217 |
$114K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
3,305 |
2,939 |
$114K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,082 |
906 |
$107K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,079 |
1,683 |
$55K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
6,056 |
5,378 |
$53K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
284 |
213 |
$33K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
497 |
428 |
$30K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
896 |
655 |
$22K |
| 90474 |
|
890 |
838 |
$18K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
438 |
302 |
$15K |
| 96127 |
|
2,960 |
2,484 |
$13K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
307 |
242 |
$10K |
| 99381 |
|
83 |
70 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
244 |
222 |
$6K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
82 |
82 |
$5K |
| 99460 |
|
83 |
83 |
$5K |
| 96161 |
|
1,042 |
857 |
$3K |
| 92551 |
|
2,037 |
1,774 |
$3K |
| 90670 |
|
1,750 |
1,536 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
204 |
195 |
$3K |
| 96160 |
|
590 |
492 |
$2K |
| 87807 |
|
163 |
115 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
15 |
14 |
$1K |
| 99173 |
|
2,553 |
2,181 |
$1K |
| 90697 |
|
583 |
481 |
$1K |
| 99070 |
|
218 |
153 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
18 |
18 |
$941.61 |
| 90680 |
|
1,467 |
1,309 |
$926.19 |
| 81002 |
|
532 |
476 |
$787.32 |
| 90734 |
|
199 |
151 |
$657.98 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
56 |
48 |
$539.54 |
| 90688 |
|
924 |
707 |
$536.72 |
| 84203 |
|
282 |
230 |
$485.02 |
| 90671 |
|
494 |
448 |
$456.90 |
| 90461 |
|
358 |
279 |
$410.22 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
12 |
12 |
$367.68 |
| 90473 |
|
19 |
17 |
$327.20 |
| 94664 |
|
33 |
33 |
$324.09 |
| 94760 |
|
2,436 |
2,075 |
$313.47 |
| 85018 |
|
273 |
265 |
$311.19 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
20 |
12 |
$290.19 |
| 87650 |
|
24 |
18 |
$222.66 |
| 90651 |
|
103 |
94 |
$220.00 |
| 90620 |
|
47 |
31 |
$200.00 |
| 97802 |
|
14 |
12 |
$166.39 |
| 90686 |
|
736 |
656 |
$115.02 |
| 99401 |
|
14 |
14 |
$76.60 |
| 90633 |
|
866 |
765 |
$32.22 |
| 90685 |
|
214 |
200 |
$0.00 |
| 90687 |
|
171 |
150 |
$0.00 |
| 90710 |
|
517 |
418 |
$0.00 |
| 90672 |
|
24 |
22 |
$0.00 |
| 90698 |
|
1,267 |
1,194 |
$0.00 |
| 90744 |
|
488 |
461 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
30 |
29 |
$0.00 |
| 90696 |
|
61 |
50 |
$0.00 |